These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 866739)

  • 21. [Growth hormone, insulin, glucemia and plasmatic free fatty acids after arginine administration (author's transl)].
    Portugal-Alvarez J; Enríquez L; Zamarrón A; Vila T; Catalá E; Velasco-Martín A
    Rev Esp Fisiol; 1973 Dec; 29(4):289-91. PubMed ID: 4791170
    [No Abstract]   [Full Text] [Related]  

  • 22. [Response of growth hormone (HGH) to L-dopa, L-arginine and their combination in normal individuals].
    Hernández Armas J; González García C; Rodríguez I
    Med Clin (Barc); 1982 Nov 1-15; 79(8):365-9. PubMed ID: 6757593
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amantadine attenuates response alterations resulting from repetitive L-DOPA treatment in rats.
    Karcz-Kubicha M; Quack G; Danysz W
    J Neural Transm (Vienna); 1998; 105(10-12):1229-36. PubMed ID: 9928891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB; Scott CL; Modebe O; Bethune JE
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Function of growth hormone secretion in over 100 patients of short stature].
    Rodríguez Doreste OL; Cardenal de Valle C; Valerón Martel C
    Rev Clin Esp; 1980 Aug 15-31; 158(3-4):131-3. PubMed ID: 7001573
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of L-dopa and propranolol administration on GH secretion in essential obesity in women].
    Cabezas-Cerrato J; Mur AL; Aranguren LV; Vila T; Fernández-Cruz A
    Rev Clin Esp; 1975 Jun; 137(6):497-502. PubMed ID: 1162133
    [No Abstract]   [Full Text] [Related]  

  • 28. [Effect of L-DOPA, phentolamine, aminophylline and propranolol on growth hormone secretion in patients with normal anterior pituitary function and subjects with acromegaly].
    De la Fuente E; Souvatzoglou A; von Werder K
    Verh Dtsch Ges Inn Med; 1974; 80():1325-8. PubMed ID: 4454412
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of dihydroergotamine on growth hormone--induced lipolysis in dogs.
    Sirek A; Sirek OV; Niki A; Niki H; Przybylska K
    Horm Metab Res; 1969 Nov; 1(6):276-81. PubMed ID: 4334875
    [No Abstract]   [Full Text] [Related]  

  • 30. [Clinical studies on the activation of the GH-secreting system in man].
    Saba P; Salvadorini F; Galeone F; Tognetti G; Saba GC
    Clin Ter; 1975 Sep; 74(5):425-33. PubMed ID: 1227757
    [No Abstract]   [Full Text] [Related]  

  • 31. [Methods for assessing the somatotropic function in children].
    Antoshkina AN; Benikova EA
    Probl Endokrinol (Mosk); 1990; 36(1):80-4. PubMed ID: 2109866
    [No Abstract]   [Full Text] [Related]  

  • 32. [The arginine test in functional semeiology of the incretion of the somatotrophic hormone].
    Giordano G; Marugo M; Minuto F; Barreca T
    Folia Endocrinol; 1971; 24(3):247-67. PubMed ID: 5171726
    [No Abstract]   [Full Text] [Related]  

  • 33. Effect of prostaglandin on the secretion of human growth hormone.
    Ito H; Momose G; Katayama T; Takagishi H; Ito L
    J Clin Endocrinol Metab; 1971 Jun; 32(6):857-9. PubMed ID: 4325220
    [No Abstract]   [Full Text] [Related]  

  • 34. [Potentialization of the action of tl-dopa on the secretion of growth hormone].
    Pombo M; Paz M
    Arch Fr Pediatr; 1976; 33(7):714-5. PubMed ID: 999443
    [No Abstract]   [Full Text] [Related]  

  • 35. [Levodopa and somatotropic hormone in diabetes].
    Carducci Artenisio A; Ragonese F; Martelli G; Forte F; Campisi R; Consolo F
    Boll Soc Ital Biol Sper; 1978 Oct; 54(20):1972-7. PubMed ID: 753286
    [No Abstract]   [Full Text] [Related]  

  • 36. Interactions between a novel cholinergic ion channel agonist, SIB-1765F and L-DOPA in the reserpine model of Parkinson's disease in rats.
    Menzaghi F; Whelan KT; Risbrough VB; Rao TS; Lloyd GK
    J Pharmacol Exp Ther; 1997 Jan; 280(1):393-401. PubMed ID: 8996220
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic effects of free fatty acids during endotoxaemia in a porcine model--free fatty acid inhibition of growth hormone secretion as a potential catabolic feedback mechanism.
    Buhl M; Gjedsted J; Granfeldt A; Larsen PØ; Schmitz O; Tønnesen E; Møller N
    Horm Metab Res; 2010 May; 42(5):348-52. PubMed ID: 20195947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of pimozide on the prolactin and somatotropin responses to L-dopa, and on the somatotropin response to hypoglycemia (author's transl)].
    Hernández JM; Morales SE; López MA
    Rev Invest Clin; 1977; 29(3):201-7. PubMed ID: 918416
    [No Abstract]   [Full Text] [Related]  

  • 39. Potentiation by amantadine hydrochloride of L-dopa-induced effects in mice.
    Svensson TH; Strömberg U
    J Pharm Pharmacol; 1970 Aug; 22(8):639-40. PubMed ID: 4394549
    [No Abstract]   [Full Text] [Related]  

  • 40. Release of pre-formed free fatty acids from adipose tissue: acceleration by cyclic AMP.
    Schimmel RJ; Goodman HM
    Endocrinology; 1972 May; 90(5):1391-5. PubMed ID: 4335097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.